ABSTRACT
After a careful examination of the procedure and the needs of the patients, in 1990 we began a series of trials of Laparoscopic Supracervical Hysterectomy (LSH) with the directive of lowering morbidity. The possibility of maintaining the procedure as totally laparoscopic offered a potential simplification to the average operator. After completing a series of these procedures and comparing them to a group of demographically similar patients undergoing LAVH we found that LSH had a significantly lower morbidity. Over the next ten years we performed approximately 750 procedures with continued low morbidity while treating uteri up to 2400 grams, stage IV endometriosis, severe PID, ovarian cancer, leiomyosarcoma, and total pelvic floor prolapse. These patients continued to recover remarkably with lower than normal morbidity despite the increased complexity of the procedures. The learning curve played a role in these statistics but the clinical results were sufficient to warrant the continuation of the LSH procedure.
